Three-month daily Rifampicin and Isoniazid compared to six or nine-month Isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review

Yibeltal Assefa, Yalemzewod Assefa, Solomon Woldeyohannes, Yohhei Hamada, Haileyesus Getahun
  • European Respiratory Journal, May 2018, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.00395-2018
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1183/13993003.00395-2018

In partnership with: